allplex tm rp1 Search Results


xpert ® flu/rsv  (BioFire Defense)
90
BioFire Defense xpert ® flu/rsv
Patient selection flowchart. 1 Reasons for not reporting the results were not recorded; 2 Unacceptable specimen (eg, unlabeled, unsuitable or mislabeled) in either <t>Xpert</t> ® Flu/RSV or Allplex ™ RP1 sample
Xpert ® Flu/Rsv, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/allplex+tm+rp1/xpert/pmc07461471-163-130-16
Average 90 stars, based on 1 article reviews
xpert ® flu/rsv - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
advansure tm rv real-time rt-pcr kit  (LG Life)
90
LG Life advansure tm rv real-time rt-pcr kit
Patient selection flowchart. 1 Reasons for not reporting the results were not recorded; 2 Unacceptable specimen (eg, unlabeled, unsuitable or mislabeled) in either <t>Xpert</t> ® Flu/RSV or Allplex ™ RP1 sample
Advansure Tm Rv Real Time Rt Pcr Kit, supplied by LG Life, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/allplex+tm+rp1/advansure+tb+ntm+real+time+pcr/pmc10167401-101-30-36
Average 90 stars, based on 1 article reviews
advansure tm rv real-time rt-pcr kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Patient selection flowchart. 1 Reasons for not reporting the results were not recorded; 2 Unacceptable specimen (eg, unlabeled, unsuitable or mislabeled) in either Xpert ® Flu/RSV or Allplex ™ RP1 sample

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Patient selection flowchart. 1 Reasons for not reporting the results were not recorded; 2 Unacceptable specimen (eg, unlabeled, unsuitable or mislabeled) in either Xpert ® Flu/RSV or Allplex ™ RP1 sample

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques: Selection

Baseline characteristics (n = 914)

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Baseline characteristics (n = 914)

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques:

Venn diagram showing the number of influenza A, influenza B, and RSV detected by Xpert ® Flu/RSV and Allplex ™ RP1

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Venn diagram showing the number of influenza A, influenza B, and RSV detected by Xpert ® Flu/RSV and Allplex ™ RP1

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques:

Diagnostic agreement of Xpert ® Flu/RSV with Allplex ™ RP1 (n = 914)

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Diagnostic agreement of Xpert ® Flu/RSV with Allplex ™ RP1 (n = 914)

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques: Diagnostic Assay

Factors associated with disagreement between Xpert ® Flu/RSV and Allplex ™ RP1 in the detection of influenza A, influenza B, or RSV (univariate analysis)

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Factors associated with disagreement between Xpert ® Flu/RSV and Allplex ™ RP1 in the detection of influenza A, influenza B, or RSV (univariate analysis)

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques:

Diagnostic agreement of Xpert ® Flu/RSV with Allplex ™ RP1 by influenza season

Journal: Influenza and Other Respiratory Viruses

Article Title: Cepheid Xpert ® Flu/RSV and Seegene Allplex ™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

doi: 10.1111/irv.12799

Figure Lengend Snippet: Diagnostic agreement of Xpert ® Flu/RSV with Allplex ™ RP1 by influenza season

Article Snippet: Xpert ® Flu/RSV has been compared to quality control samples, single‐plex real‐time RT‐PCR, a laboratory‐developed assay, BioFire FilmArray (USA), and GenMark Diagnostics eSensor RVP (USA), and reported to have the following measures: (a) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza A; (b) 80%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for influenza B; and (iii) 91%‐100% PPA/sensitivity and 99%‐100% NPA/specificity for RSV., , , , Allplex TM RP has been compared to AdvanSure (Korea), Anyplex II RV16 (Korea), Simplexa TM Flu A/B & RSV (USA), and quality control samples and reported to have 90%‐98% PPA/sensitivity and 100% NPA/specificity for influenza A, 89%‐100% PPA/sensitivity and 100% NPA/specificity for influenza B, and 95%‐100% PPA/sensitivity and 100% NPA/specificity for RSV., , , A study by Gimferrer et al is the only study that has assessed both Xpert ® Flu/RSV and Allplex TM RP1 against the same reference assay.

Techniques: Diagnostic Assay